0001140361-23-010157.txt : 20230303
0001140361-23-010157.hdr.sgml : 20230303
20230303204950
ACCESSION NUMBER: 0001140361-23-010157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dietz Thomas John
CENTRAL INDEX KEY: 0001574218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 23707273
MAIL ADDRESS:
STREET 1: C/O TRANSCEPT PHARMACEUTICAL, INC.
STREET 2: 1003 W. CUTTING BLVD, STE 110
CITY: PT. RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
form4.xml
X0306
4
2023-03-01
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001574218
Dietz Thomas John
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BOULEVARD
PALO ALTO
CA
94306
true
Stock Option (Right to Buy)
1.705
2023-03-01
4
A
0
40000
0
A
2033-02-28
Common Stock
40000
40000
D
The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date.
/s/ Thomas J. Dietz
2023-03-03